The Effect Of Virtual Reality Glasses On The Behavior Of Children With Autism Spectrum Disorder
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03853265 |
|
Recruitment Status :
Completed
First Posted : February 25, 2019
Last Update Posted : November 9, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Autism Spectrum Disorder | Behavioral: Simulated dental office visit | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 5 participants |
| Allocation: | Randomized |
| Intervention Model: | Sequential Assignment |
| Intervention Model Description: | Study is parallel design with control group having the option of receiving treatment after study data is collected from initial treatment group |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | The Effect Of Virtual Reality Glasses On The Behavior Of Children With Autism Spectrum Disorder |
| Actual Study Start Date : | October 23, 2019 |
| Actual Primary Completion Date : | February 17, 2020 |
| Actual Study Completion Date : | February 17, 2020 |
| Arm | Intervention/treatment |
|---|---|
| No Intervention: Control | |
|
Experimental: Virtual Reality
Simulated dental office visit
|
Behavioral: Simulated dental office visit
An immersive first-person point of view (POV) video simulation of the dental office in the three-dimensional environment (using a virtual reality headset) which allows participant to look around the room as they move down the hallways which is to be watched/experienced by the participant as often as possible between the initial visit and the follow up visit |
- Change in heart rate [ Time Frame: Baseline to 2 week follow up ]Heart rate measured by a fitbit worn on the wrist during the visit
- Change in 5-point Venham Anxiety Scores [ Time Frame: Baseline to 2 week follow up ]Level of Anxiety exhibited by participant during dental visit as rated on Venham Anxiety Scale by blinded expert rater. Scale ranges from 0 (relaxed, smiling, willing and able to converse) to 5 (child out of contact with the reality of the threat, loud crying, unable to listen to verbal communication, actively involved in escape behavior).
- Change in 5-point Venham Uncooperative Behavior Scores [ Time Frame: Baseline to 2 week follow up ]Cooperative behaviors exhibited by participant during dental visit as rated on Venham Uncooperative Behavior Scale by blinded expert rater. Scale ranges from 0 (total cooperation, no crying or physical protest) to 5 (general protest, no compliance or cooperation)
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 5 Years to 25 Years (Child, Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Autism Spectrum Disorder (ASD)
Exclusion Criteria:
- No specific diagnosis of Autism Spectrum Disorder (ASD)
- Limited English Proficiency
- Existing patient of VCU Department of Pediatric Dentistry
- Parent/guardian determination that child would not be avle to tolerate immersive simulation with VR glasses
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03853265
| United States, Virginia | |
| Virginia Commonwealth University | |
| Richmond, Virginia, United States, 23298 | |
| Principal Investigator: | Tegwyn Brickhouse, DDS | Virginia Commonwealth University |
| Responsible Party: | Virginia Commonwealth University |
| ClinicalTrials.gov Identifier: | NCT03853265 |
| Other Study ID Numbers: |
HM20015131 |
| First Posted: | February 25, 2019 Key Record Dates |
| Last Update Posted: | November 9, 2020 |
| Last Verified: | November 2020 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Autistic Disorder Autism Spectrum Disorder Child Development Disorders, Pervasive Neurodevelopmental Disorders Mental Disorders |

